Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores
Titel:
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores
Auteur:
Vogelmeier, Claus F. Rabe, Klaus F. Bhatt, Surya P. Hanania, Nicola A. Bafadhel, Mona Christenson, Stephanie A. Papi, Alberto Singh, Dave Laws, Elizabeth Maloney, Jennifer Dakin, Paula Lu, Xin Bauer, Deborah Bansal, Ashish Robinson, Lacey B. Abdulai, Raolat M.